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Chiorothiazide and hydrochiorothiazide are
widely used today as oral diuretic and anti-hyper-
tensive agents (1, 2, 3, 4). They are aromatic sul-
fonamides (5) and are chemically identical except
for the degree of hydrogen saturation. Although
numerous cases of photosensitivity due to sulfon-
amides have been reported and have been exten-
sively investigated, to date we could find only one
report of a case of photosensitivity due to chloro-
thiazide (6). However, several authors have
recently reported apparently non-photosensitive
macular, morbilliform, petechial and purpuric
drug eruptions due to chlorothiazide (3, 4, 7, 8).
We have also seen such non-photosensitive drug
eruptions, but they are not the subject of this
preliminary report.
Three cases of photosensitive eruptions due to
chlorothiazide and hydrochlorothiazide and the
action spectrum eliciting these eruptions have
been studied.
Case 1. A66 year-old white woman was seen with
a lichen planus -like eruption confined to the light-
exposed areas. Although clinically and histologi-
cally identical with lichen planus, no lesions were
noted on the flexural surfaces or the oral mucosa.
This eruption had followed exposure to sunlight
while the patient was receiving hydrochlorothi-
azide 25 mg. b.i.d. for cardiac disease. Rapid
improvement occurred upon discontinuation of
this drug and subsequent exposure to sunlight has
been well tolerated.
Case 2. A 71 year-old white woman presented a
violaceous, papular eruption confined to the dorsa
of both hands. The lesions were clinically and
histologically identical with lichen planus. This
eruption had followed exposure to sunlight while
the patient was receiving chlorothiazide therapy.
Ninety per cent improvement in the eruption was
noted two weeks after chlorothiazide was discon-
tinued and subsequent exposure to sunlight has
been tolerated well.
Case 3. A 60 year-old obese white woman pre-
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sented a severe eruption confined to the light
exposed areas of the face, arms and legs. This
consisted of edematous, erythematous plaques
which were studded with vesicles. This was the
second such episode in a two month period, both
outbreaks having followed exposure to sunlight
while she was taking chlorothiazide 500 mg. daily.
In each instance rapid improvement followed
withdrawal of the medication.
In order to ascertain whether the occurrence of
these eruptions required the presence of both the
drug and sunlight, the following tests were per-
formed: After having received no hydrochlorothi-
azide or chlorothiazide for at least one week, pa-
tients reported as cases 1 and 3 were given ery-
thema doses of sunshine; no abnormal responses
were noted. The drug was then readministered
while avoiding direct exposure to sunlight, but
improvement of the skin lesions continued.
Thereupon the patient reported as Case 1 once
more was given hydrochlorothiazide 25 mg. b.i.d.
and 48 hours later a previously uninvolved 4 inch
square skin area in the lumbar region was exposed
to unfiltered sunlight. Six to eight hours later the
test area showed a reaction of hypersensitivity
consisting of an abnormally intense local area of
erythema and edema. Furthermore, although the
rest of the body had been protected as carefully as
possible against sun exposure, there was a marked
exacerbation, i.e. "flare up", of the lesions in the
previously involved sites.
The action spectrum responsible for these photo-
sensitive reactions was ascertained using both
natural light and carbon arc (Sunshine® carbons),
radiation. A Corex D filter which does not transmit
wavelengths shorter than 2750 A and a 3 mm. thick
pane of window glass which prevents passage of
wavelengths longer than 3100 A were used.
In Case 1 exposure to unfiltered sunlight and
carbon arc radiation with a Corex D filter after
ingestion of hydrochlorothiazide elicited an ab-
normally intense erythema in the deliberately
exposed sites, and caused an exacerbation in the
unexposed but previously involved sites. However,
sunlight or carbon arc radiation which had passed
through window glass resulted in no reaction.
Studies with carbon arc radiation in Case 2 indi-
cated that the same wavelength range as that in
Case 1 elicited the photosensitive reaction due to
chlorothiazide.
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It therefore appears that the action spectrum of
both compounds is in the wavelength range from
2750 A and 3100 A. This spectral range coincides
with high peaks of light absorption of these two
compounds (9).
CONCLUSIONS
1. Three patients with photosensitive eruptions
due to chiorothiazide and hydrochlorothiazide
are described and investigated.
2. Two of these patients had the morphological
and histopathological teatures of lichen planus
while the eruption in the third was vesicular and
erythematous.
3. The action spectrum in photosensitization
due to these drugs was shown to be in the wave-
length range between 2750 A and 3100 A, i.e., in
the sunburn part of the ultraviolet spectrum.
4. While the exact mechanism producing these
reactions of photosensitivity is not clear, the evi-
dence suggests a photoallergic rather than a pho-
totoxic effect.
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